Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Tandem Diabetes Care (TNDM) Gross Margin (2016 - 2025)

Historic Gross Margin for Tandem Diabetes Care (TNDM) over the last 13 years, with Q3 2025 value amounting to 53.88%.

  • Tandem Diabetes Care's Gross Margin rose 27800.0% to 53.88% in Q3 2025 from the same period last year, while for Sep 2025 it was 53.23%, marking a year-over-year increase of 34300.0%. This contributed to the annual value of 52.07% for FY2024, which is 29000.0% up from last year.
  • Per Tandem Diabetes Care's latest filing, its Gross Margin stood at 53.88% for Q3 2025, which was up 27800.0% from 52.29% recorded in Q2 2025.
  • Tandem Diabetes Care's Gross Margin's 5-year high stood at 55.71% during Q4 2024, with a 5-year trough of 47.41% in Q4 2023.
  • Moreover, its 5-year median value for Gross Margin was 51.78% (2022), whereas its average is 51.59%.
  • Its Gross Margin has fluctuated over the past 5 years, first crashed by -49800bps in 2023, then surged by 83000bps in 2024.
  • Over the past 5 years, Tandem Diabetes Care's Gross Margin (Quarter) stood at 54.16% in 2021, then fell by -3bps to 52.39% in 2022, then fell by -10bps to 47.41% in 2023, then increased by 18bps to 55.71% in 2024, then fell by -3bps to 53.88% in 2025.
  • Its Gross Margin was 53.88% in Q3 2025, compared to 52.29% in Q2 2025 and 50.51% in Q1 2025.